Campbell & Co Investment Adviser’s GoodRx Holdings GDRX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-44,700	Closed	-$189K	–	1233
2025 Q3	$189K	Sell	44,700 -60,007	-57%	-$264K	0.01%	1013
2025 Q2	$521K	Sell	104,707 -473	-0.4%	-$2.05K	0.03%	769
2025 Q1	$464K	Buy	105,180 +13,336	+15%	+$62.6K	0.04%	710
2024 Q4	$427K	Buy	91,844 +3,580	+4%	+$19.7K	0.03%	716
2024 Q3	$613K	Buy	88,264 +31,592	+56%	+$248K	0.05%	628
2024 Q2	$442K	Buy	+56,672	New	+$420K	0.04%	698
2024 Q1	–	Sell	-10,424	Closed	-$69.8K	–	1206
2023 Q4	$69.8K	Sell	10,424 -25,204	-71%	-$142K	0.01%	1066
2023 Q3	$201K	Buy	+35,628	New	+$238K	0.02%	854

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Campbell & Co Investment Adviser's GDRX Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of GoodRx Holdings (GDRX) in Q4 2025, closing a stake of 44,700 shares — an estimated $189K sold.

Campbell & Co Investment Adviser first reported a position in GDRX in Q3 2023 and held it in 8 quarters. The position peaked at $613K in Q3 2024. 183 funds tracked by Wall St. Rank hold GDRX as of Q4 2025.

Campbell & Co Investment Adviser reported no remaining GoodRx Holdings position as of Q4 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 44,700 GoodRx Holdings shares in Q4 2025, an estimated $189K.
Campbell & Co Investment Adviser first reported a position in GoodRx Holdings in Q3 2023 and held it in 8 quarters.
Campbell & Co Investment Adviser's GoodRx Holdings position peaked at $613K in Q3 2024.
183 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.